Eiseman, JL and Bai, L and Jung, WH and Moura-Letts, G and Day, BW and Curran, DP
(2008)
Improved synthesis of 6-epi-dictyostatin and antitumor efficacy in mice bearing MDA-MB231 human breast cancer xenografts.
Journal of Medicinal Chemistry, 51 (21).
6650 - 6653.
ISSN 0022-2623
![[img]](http://d-scholarship.pitt.edu/style/images/fileicons/text_plain.png) |
Plain Text (licence)
Available under License : See the attached license file.
Download (1kB)
|
Abstract
Structure-activity studies centered on the naturally occurring antitumor agent dictyostatin have recently identified several highly active epimers and analogues. From these compounds, 6-epi-dictyostatin was selected for scaleup preparation and evaluation in animals. Here we describe a new total synthesis that produced more than 30 mg of 6-epi-dictyostatin. The compound was found to have potent antitumor activity in SCID mice bearing MDA-MB231 human breast cancer xenografts. © 2008 American Chemical Society.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
|
Date: |
13 November 2008 |
Date Type: |
Publication |
Journal or Publication Title: |
Journal of Medicinal Chemistry |
Volume: |
51 |
Number: |
21 |
Page Range: |
6650 - 6653 |
DOI or Unique Handle: |
10.1021/jm800979v |
Schools and Programs: |
Dietrich School of Arts and Sciences > Chemistry |
Refereed: |
Yes |
ISSN: |
0022-2623 |
MeSH Headings: |
Animals; Body Weight--drug effects; Breast Neoplasms--drug therapy; Breast Neoplasms--pathology; Cell Line, Tumor; Disease Progression; Female; Humans; Macrolides--chemical synthesis; Macrolides--chemistry; Macrolides--therapeutic use; Mice; Xenograft Model Antitumor Assays |
Other ID: |
NLM NIHMS86529, NLM PMC2627582 |
PubMed Central ID: |
PMC2627582 |
PubMed ID: |
18839939 |
Date Deposited: |
01 Mar 2013 15:47 |
Last Modified: |
02 Feb 2019 15:58 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/17615 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
 |
View Item |